Sequence phase | |||
---|---|---|---|
Electroacupuncture first (n = 17) | Sham first (n = 17) | P | |
Age (years) | 39.11 (±10.5) | 41.44 (±10.5) | 0.36 |
Formal education (years of study) | 14.44 (±3.9) | 14.21 (±2.9) | 0.85 |
Clinical comorbidity | 4 (22%) | 2 (12.5%) | 0.66 |
Smoking | 1 (5.5%) | 0 | 1.00 |
Pain on the 10-cm VAS | 6.02 (±1.5) | 6.50 (±1.4) | 0.28 |
HIT-6 | 63.00 (±6.4) | 61.44 (±5.2) | 0.44 |
HDRS | 7.83 (±3.8) | 6.69 (±2.8) | 0.33 |
Psychiatric disease | 6 (33.3%) | 4 (25%) | 0.59 |
B-PCS | 32.17 (±13.5) | 27.81 (±15.1) | 0.38 |
Helplessness | 14.17 (±6.9) | 12.25 (±7.1) | 0.43 |
Magnification | 7.11 (±3.4) | 5.69 (±3.8) | 0.26 |
Rumination | 10.78 (±3.7) | 9.88 (±5,03) | 0.55 |
Serum BDNF (ng/mL) | 42.67 (±34.6) | 43.2 (±21.4) | 0.95 |
Daily use of analgesics (Yes/No) | 14/3 | 15/2 | 0.66 |
Dorflex® | 10 | 12 | |
NSAID | 4 | 2 | |
Acetaminophen | 4 | 2 | 0.81 |